International prognostic index, type of transplant and response to rituximab are key parameters to tailor treatment in adults with CD20-positive B cell PTLD: clues from the PTLD-1 trial.
| Image |  |
|---|---|
| Description | scientific article published on 3 March 2015 |
| Author/s |
author: Peter Mollee Arnaud Jaccard Ralf Trappe Petra Reinke |
| Publication date | March 3, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |